Let me preface this by saying that I still view this company positively. $25M more, to make the $100M should come from the Medicine Man Dispensaries...however with Bob DeGabrelle resigning (which we all questioned), only to see his deal drop...whatever...just makes me wonder if all the sour Andy Williams questions that we had will turn into a termed agreement with their dispensaries/Medpharm as well. I sure hope not!...but if it does it also makes the company name change make sense.
Any idea what the diluted share count will be without these deals? Prior to the contract terminations it was estimated at 105M shares. (With 100M revenue) If it is 75M or less the share price might actually end up higher than it would have being fully diluted with the estimated $144M revenue they were telling us.
Depending on how it turns out, this loss might be our (shareholder) biggest win.
News 
Market Data 
Discover 
